Macrophages in Tumor Microenvironments and the Progression of Tumors
Open accessThe DOI matches its Crossref record; 120 of the 121 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Macrophages are widely distributed innate immune cells that play indispensable roles in the innate and adaptive immune response to pathogens and in-tissue homeostasis. Macrophages can be activated by a variety of stimuli and polarized to functionally different phenotypes. Two distinct subsets of macrophages have been proposed, including classically activated (M1) and alternatively activated (M2) macrophages. M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II. In contrast, M2 macrophages express a wide array of anti-inflammatory molecules, such as IL-10, TGF-β, and arginase1. In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. Recently, it was also found that tumor-associated macrophages interact with cancer stem cells. This interaction leads to tumorigenesis, metastasis, and drug resistance. So mediating macrophage to resist tumors is considered to be potential therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, many other neoplasms are associated with M2-like TAMs that secrete immunosuppressive cytokines that promote tumor growth and metastasis (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, TAMs induce immunosuppression via release of IL-10 and TGF-β, both of which inhibit the development of cytotoxic T cells and NK cells, and may fuel the appearance of more M2-like TAMs at the tumor site (8, 67, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In cancer, tumor-associated macrophages (TAMs) have been known to either promote or hinder neoplasia (8, 90).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [90]
In the citing paper
“In contrast, M2 macrophages (CD163) play an anti-inflammatory and pro-tumor role”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
In the citing paper
“TAMs often exhibit an “M2-like” phenotype [324].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [324]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 2×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 4×
“Several studies reporting the use of “antimacrophage” approaches have primarily focused on counteracting monocyte chemokines and receptors as anticancer targets [10, 14, 36, 42].”
BackgroundInfluentialMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“, tumor necrosis factor-α (TNF-α)) [6] (Figure 1).”
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“Finally, the monocytes migrate into different tissues and replenish the populations of long-lived tissue-specific macrophages, such as alveolar macrophages and kupffer cells [2, 3].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Alternative Activation of Macrophages: An Immunologic Functional Perspective
Martinez, F. O., Helming, L., & Gordon, S. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132532 · Cited by 2,745 · cited 1×
“Finally, M2c macrophages are induced by IL-10, transforming growth factor-β (TGF-β), or glucocorticoids (GCs) [7] (Figure 1).”
BackgroundMacrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 7×
“M1 macrophages express a series of proinflammatory cytokines, chemokines, and effector molecules, such as IL-12, IL-23, TNF-α, iNOS and MHCI/II.”
BackgroundInfluentialInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 1×
“IL-23, which is also secreted by M1 macrophages, is associated with the development and expansion of Th17 cells, which can secrete high levels of IL-17 and contribute to inflammatory autoimmune pathologies [17, 18].”
BackgroundCancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343 · cited 1×
“Chemokines, such as CCL17 and CCL22, can prevent the infiltration of cytotoxic T-cells but promote that of Treg and Th2 cells [38, 94].”
Background
Research works printed but not linked: 12
- 2008, Journal of Immunology, 15, 3733
- 2002, American Journal of Pathology, 161, 947, 10.1016/s0002-9440(10)64255-1 · DOI · Paper page
- 2005, Oncology Reports, 14, 425
- 1996, Journal of Immunology, 156, 73
- 1997, Journal of Immunology, 159, 770
- 1995, Journal of Immunology, 154, 1280
- 2000, Cancer Research, 60, 2632
- 1999, International Journal of Cancer, 84, 539
- 1984, Annual Review of Immunology, 2, 283, 10.1146/annurev.iy.02.040184.001435 · doi:10.1146/annurev.iy.02.040184.001435 · Paper page
- 2003, Cancer Research, 63, 8360
- 1995, Cancer Research, 55, 1499
- 2003, Cancer Research, 63, 7853
Cited by
Items 501–600 of 1,000
Stinson, M. W., Liu, S., Laurenson, A. J., & Rotty, J. D. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-04-0137 · Cited by 24
“Many disease states manifest with chronic inflammation, which may be due in part to dysregulated macrophage activation (Hao et al. , 2012; Yang and Ming, 2014; Buchacher et al. , 2015; Ma et al. , 2016; Schliefsteiner et al. , 2017).”
New insights into the role of the oral leukoplakia microenvironment in malignant transformation
González‐Arriagada, W. A., Canedo-Marroquín, G., Adorno-Farías, D., & Fernández‐Ramires, R. (2024) · Frontiers in Oral Health · doi:10.3389/froh.2024.1363052 · Cited by 23
“M1 macrophages, on the other hand, are typically associated with pro-in fl ammatory responses in host defense that are necessary for an ef fi cient immune response to potentially malignant lesions (52).”
BackgroundA simplified culture system to examine soluble factor interactions between mammalian cells
Carroll, M. J., Stopfer, L. E., & Kreeger, P. K. (2013) · Chemical Communications · doi:10.1039/c3cc47507g · Cited by 23
Marcuello, M., Mayol, X., Felipe-Fumero, E., Costa, J., López-Hierro, L., Salvans, S., Alonso, S., Pascual, M., Grande, L., & Pera-Román, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192958 · Cited by 26
Cao, Y., Xu, Y., Auchoybur, M. L., Chen, W., He, S., Qin, W., Su, C., Huang, F., Qiu, Z., Li, L., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.08.021 · Cited by 24
Self-citationImmunosuppressive Phenotype of Esophagus Tumors Stroma
Kovaleva, O. V., Rashidova, M. A., Samoilova, D. V., Алексеевна, П. П., Mochalnikova, V. V., & Gratchev, A. N. (2020) · Analytical Cellular Pathology · doi:10.1155/2020/5424780 · Cited by 23
“In most of the tumors, TAMs have M2 phenotype that are considered to be tumorsupporting ones [21].”
BackgroundTumor-associated macrophages: Potential target of natural compounds for management of breast cancer
Malla, R. R., Padmaraju, V., & Kundrapu, D. B. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120572 · Cited by 25
Cripto-1 modulates macrophage cytokine secretion and phagocytic activity via NF-κB signaling
Zhang, D., Bao, Y., Yu, C., Wang, Y., & Song, Z. (2015) · Immunologic Research · doi:10.1007/s12026-015-8724-3 · Cited by 23
A Review of Monocytes and Monocyte-Derived Cells in Hypertrophic Scarring Post Burn
Suda, S., Williams, H., Medbury, H., & Holland, A. (2016) · Journal of Burn Care & Research · doi:10.1097/bcr.0000000000000312 · Cited by 21
Macrophages As Delivery Vehicles for Anticancer Agents
Madsen, S. J., & Hirschberg, H. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0004 · Cited by 24
He, D., Wang, L., Xu, J., Zhao, J., Bai, H., & Wang, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1265865 · Cited by 22
“Both neutrophils and TAMs promote angiogenesis by secreting proangiogenic factors, such as VEGF, TNF-a , IL-8, and various chemokines including CXCR-2, 4 and 12, CXCL-3, 4, 8, 9, 10, and CCL2-5 (21).”
BackgroundSingh, K., & Gautam, P. K. (2023) · BMC Cancer · doi:10.1186/s12885-023-11674-9 · Cited by 22
“Macrophages play a dual role in cancer, with M1 macrophages exhibiting anti-tumour properties, while M2 macrophages promote tumour growth and immune evasion [4].”
BackgroundInfluentialDenis, I., Cellerin, L., Grégoire, M., & Blanquart, C. (2014) · Oncotarget · doi:10.18632/oncotarget.2604 · Cited by 22
“Among all cells present in the environment of the tumor, macrophages are of significant importance and have been described as enhancers of tumor cell proliferation [28].”
BackgroundSilva, I., Stone, S. C., Rossetti, R. A. M., Jancar, S., & Lepique, A. P. (2017) · Journal of Immunology Research · doi:10.1155/2017/5482768 · Cited by 22
La, X., Zhang, L., Yang, Y., Li, H., Song, G., & Li, Z. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.04.004 · Cited by 22
RetractedZhang, Y., Wang, S., Liu, Z., Yang, L., Liu, J., & Xiu, M. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14342 · Cited by 22
RetractedA generalizable data-driven multicellular model of pancreatic ductal adenocarcinoma
Aguilar, B. H., Gibbs, D. L., Reiss, D. J., McConnell, M. T., Danziger, S. A., Dervan, A., Trotter, M. W. B., Bassett, D. E., Hershberg, R. M., Ratushny, A. V., et al. (2020) · GigaScience · doi:10.1093/gigascience/giaa075 · Cited by 24
GRP78 plays an integral role in tumor cell inflammation-related migration induced by M2 macrophages
Zhang, L., Li, Z., Ding, G., La, X., Yang, P., & Li, Z. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.06.008 · Cited by 23
Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia
Grega, T., Vojtěchová, G., Gregová, M., Zavoral, M., & Suchánek, Š. (2021) · Physiological Research · doi:10.33549/physiolres.934631 · Cited by 21
“An dysregulated M1/M2 macrophage balance also explains carcinogenesis in obese patients with T2DM (Hao et al. 2012).”
BackgroundZwager, M. C., Bense, R. D., Waaijer, S. J. H., Qiu, S.-Q., Timmer‐Bosscha, H., de Vries, E. G. E., Schröder, C. P., & van der Vegt, B. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06859-y · Cited by 23
IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma
Hussain, S. M., Reed, L. F., Krasnick, B. A., Miranda‐Carboni, G. A., Fields, R. C., Bi, Y., Elahi, A. H., Ajidahun, A. O., Dickson, P. V., Deneve, J. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24194-5 · Cited by 22
Wang, J., Wang, X., Wang, Y., Li, S., & Wang, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1550570 · Cited by 21
“In many clinical and basic researches in recent years, it has been found that macrophages play a role in promoting tumor growth and metastasis which are called tumor associated macrophages (TAMs).(12,13) Macrophages can be activated into different forms under different circumstances.”
BackgroundWoo, J., Ahn, J., Jang, D. S., & Choi, J. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500666 · Cited by 22
Musashi-1 Regulates MIF1-Mediated M2 Macrophage Polarization in Promoting Glioblastoma Progression
Yang, Y., Chien, C., Yarmishyn, A. A., Chan, M.-S., Lee, A. C.-L., Chen, Y.-W., Huang, P., Ma, H., Lo, W., Chien, Y., et al. (2021) · Cancers · doi:10.3390/cancers13081799 · Cited by 21
“An increasing number of reports have documented the importance of various subtypes of macrophages in the tumor microenvironment [35,36].”
BackgroundAbnormal Macrophage Polarization in Patients with Myelodysplastic Syndrome
Zhang, G., Yang, L., Han, Y., Niu, H., Li, Y., Shao, Z., Xing, L., & Wang, H. (2021) · Mediators of Inflammation · doi:10.1155/2021/9913382 · Cited by 23
“Studies have shown that tumor-associated macrophages (TAMs) are similar to M2 macrophages, and the M2D subtype is considered to be tumor-associated macrophages [13].”
Passman, A. M., Strauss, R. P., McSpadden, S. B., Finch‐Edmondson, M., Andrewartha, N., Woo, K. H., Diepeveen, L. A., Zhao, W., Fernández‐Irigoyen, J., Santamaría, E., et al. (2021) · Cancers · doi:10.3390/cancers13194935 · Cited by 21
“In many tumours, infiltrating macrophages are predominantly the “alternative” M2-like type, providing an immunosuppressive environment that encourages tumour growth [41].”
BackgroundIn vitro inflammatory effects of hard metal (WC–Co) nanoparticle exposure
Armstead, A., & Li, B. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s121141 · Cited by 22
Progress in Tumor‐Associated Macrophages: From Bench to Bedside
Wang, Y., Lin, Y., Qiao, S., Wang, J., & Wang, H. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800232 · Cited by 21
The role of macrophages in renal fibrosis and therapeutic prospects
Niu, D., Yang, J. J., & He, D. (2025) · PeerJ · doi:10.7717/peerj.19769 · Cited by 20
“M2d macrophages, which are activated by TLR ligands and A2 adenosine receptor agonists, play a pivotal role in regulating tumor progression, angiogenesis, and metastasis ( Hao et al., 2012 ; Li et al., 2023a ).”
Post-translational governance of NF-κB in cancer immunity: mechanisms and therapeutic horizons
Hong, Y., Fu, Y., & Long, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1627084 · Cited by 22
SEMA4D Knockdown Attenuates β‐Catenin‐Dependent Tumor Progression in Colorectal Cancer
Rezaeepoor, M., Rashidi, G., Pourjafar, M., Mohammadi, C., Solgi, G., & Najafi, R. (2021) · BioMed Research International · doi:10.1155/2021/8507373 · Cited by 20
“Interestingly, CSCs can participate in TAMs infiltration and polarization in tumor stroma [39].”
BackgroundLocal Biomarkers Involved in the Interplay between Obesity and Breast Cancer
Holm, J. B., Rosendahl, A. H., & Borgquist, S. (2021) · Cancers · doi:10.3390/cancers13246286 · Cited by 24
Diverse Macrophages Constituted the Glioma Microenvironment and Influenced by PTEN Status
Zhou, F., Shi, Q., Fan, X., Yu, R., Wu, Z., Wang, B., Tian, W., Yu, T., Pan, M., You, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.841404 · Cited by 20
“In the tumor microenvironment, M2 macrophages play immune-suppressive roles via promoting tumor development (12).”
BackgroundLee, C., Lee, H., Cho, H., Kim, S., Choi, I., Hwang, Y., Jeong, H., Jang, H., Pak, S., Hwang, D., et al. (2022) · 癌症:英文版 · doi:10.1002/cac2.12276 · Cited by 20
“of these cells by overexpressing PD-L1 and CTLA4 [5, 9].”
BackgroundInfluentialJang, S., Han, H., Oh, Y., & Kim, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28121 · Cited by 20
Cancer therapeutic potential of combinatorial immuno- and vasomodulatory interventions
Hatzikirou, H., Alfonso, J. C. L., Mühle, S., Stern, C., Weiss, S., & Meyer‐Hermann, M. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.0439 · Cited by 21
“Recent advances have indicated that tumor-associated macrophages actively promote all aspects of tumor initiation, progression and development [75].”
BackgroundLi, X., Wang, Z., Zou, Y., Lu, E., Duan, J., Yang, H., Wu, Q., Zhao, X., Wang, Y., You, L., et al. (2015) · Immunologic Research · doi:10.1007/s12026-015-8644-2 · Cited by 20
“Indeed, the recruitment of Tregs to liver usually occurs through cell-to-cell contact in PD-L1-dependent manner by macrophages [25, 26], so we utilized Western blot to determine whether PD-L1 expression was altered in the liver of LPS-/DEN-treated mice.”
MethodTsai, A. K., & Dávila, E. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1122158 · Cited by 21
Li, X., Wang, P., Zhu, J., Yi, J., Ji, Z., Kang, Q., Hao, L., Huang, J., & Lu, J. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.126716 · Cited by 20
Huang, C., Liu, L.-X., & Shyr, C. (2020) · Anticancer Research · doi:10.21873/anticanres.14243 · Cited by 21
Peng, H. C., Wang, J., Guo, F., Zhu, F.-F., Wen, Z.-J., Zhong, H., & Liang, D.-S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111442 · Cited by 20
Huang, M., Liu, L., Zhu, J., Jin, T., Chen, Y., Xu, L., Cheng, W., Ruan, X., Su, L., Meng, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.723817 · Cited by 24
“Macrophages, including M1 and M2 macrophages, are an important part of innate and adaptive immunity (Hao et al., 2012).”
BackgroundGaremilla, S. S. S., Gampa, S. C., & Garimella, S. V. (2025) · Medical Oncology · doi:10.1007/s12032-025-02754-w · Cited by 21
“These cytokines not only directly suppress effector T cell functions but also promote the development of tolerogenic dendritic cells, further dampening anti-tumor immune responses [65].”
Immune cell-based therapies for solid tumors, current challenges and therapeutic advances
Torabi, S., Yekzaman, E., Taherkhani, S., Talachi, N., Khoshravesh, R., Khosravi, A., Salehi, M., Zarrabi, A., & Vosough, M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02632-y · Cited by 22
“Macrophages (MQs) are a type of white blood cell that plays a vital role in the immune system, serving as the first line of defense against foreign substances, infection, and disease [23].”
Król, M., Mucha, J., Majchrzak, K., Homa, A., Bulkowska, M., Majewska, A., Gajewska, M., Pietrzak, M., Perszko, M., Romanowska, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083995 · Cited by 19
“There are also some reports available about experimental anti-macrophage treatment [45,46] for metastatic cancers.”
RetractedMyeloid Derived Suppressor Cells
Fujimura, T., & Enk, A. (2016) · Springer eBooks · doi:10.1007/978-4-431-55855-2_11 · Cited by 19
Zhu, M., Li, X., Xu, C. W., Ye, F., Ye, F., Li, X., Hu, Z., Zhang, L., Nie, J. J., & Li, X. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01252-6 · Cited by 19
Immunodynamics of Macrophages in Renal Fibrosis
Chung, J. Y., Zhang, Y.-Y., Ji, Z. Z., Tang, T., Chen, J., Tang, S. C. W., & Tang, P. M.-K. (2023) · Integrative Medicine in Nephrology and Andrology · doi:10.1097/imna-d-23-00001 · Cited by 19
“[18] Recent studies have suggested that tumor-associated macrophages are a novel M2 subgroup called M2d [Figure 1].[19]”
Zhang, C., Wang, M., & Wu, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1278863 · Cited by 22
Ruocco, M. R., Gisonna, A., Acampora, V., D'Agostino, A. G., Carrese, B., Santoro, J., Venuta, A., Nasso, R., Rocco, N., Russo, D., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116224 · Cited by 22
“This process occurs through the dysregulation of the TCR pathway, and it emphasizes the complex interplay between immune cells and the TME in shaping the anti-tumor immune response [129].”
BackgroundLee, S. W., Kim, S., Kim, B., Seong, J. B., Park, Y., Lee, H. J., Choi, D. K., Yeom, E., & Lee, D. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00911-x · Cited by 19
“Moreover, M2 macrophages provide a favorable tumor microenvironment for growth, survival, and angiogenesis (Hao et al. 2012, Sica and Mantovani 2012).”
BackgroundHu, Y. Y., Paris, S., Sahoo, N., Wang, Q., Wang, Q., Barsoumian, H. B., Huang, A., SILVA, J. D., Bienassis, C., Leyton, C. S. K., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02855-0 · Cited by 19
“Additionally, M1 macrophages exhibit high expression levels of MHC class II molecules and co-stimulatory molecules, including CD86 and CD80, that are vital for T cell activation [84, 85].”
BackgroundTong, W., Xu, H., Tang, J., Zhao, N., Zhou, D., Chen, C., & Cao, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-76052-2 · Cited by 19
“The presence of inflammatory cells and their responses within the tumor can facilitate tumor growth, progression, and immune evasion, rather than eliciting effective anti-tumor activities 7 .”
BackgroundChen, Z., Dong, F., Lu, J., Wei, L., Tian, L., Ge, H., Zou, Y., Ma, X., Yang, Y., Zhou, L., et al. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.08.008 · Cited by 20
Vitale, G., Carra, S., Ferraù, F., Guadagno, E., Faggiano, A., & Colao, A. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102840 · Cited by 19
Ramesh, A., Malik, V., Karuppiah, H. A. R., Smith, H., & Kulkarni, A. A. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01040-2 · Cited by 19
Gum Arabic in combination with IFN-γ promotes the M1 polarization in macrophage
Lin, C., Chen, W., Huang, Y., Lim, C. L., & Yang, C. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.04.024 · Cited by 19
Han, Y. K., Park, G., Bae, M., Kim, J., Jo, W. S., & Lee, C. (2019) · Oncology Letters · doi:10.3892/ol.2019.10986 · Cited by 19
“including M2‐type TAMs, or recruit myeloid‐derived suppressor cells (5,6).”
BackgroundMacrophages: diversity of phenotypes and functions, interaction with foreign materials
Sarbaeva, N. N., Ponomareva, J. V., & Milyakova, M. N. (2016) · Genes and Cells · doi:10.23868/gc120550 · Cited by 31
Nitric oxide-modulating biomaterials for therapeutic Immunoengineering
Boo, Y., Choi, S., Kim, J., & Kim, W. J. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115718 · Cited by 18
Export of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring Cells
Jahagirdar, D., Purohit, S., Jain, A. Y., & Sharma, N. K. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00147 · Cited by 18
Lee, C., Kim, S., Jeong, C., Cho, I., Jo, J., Han, I., & Bae, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042157 · Cited by 18
“Furthermore, M2-like macrophages have been demonstrated to cause dysregulation of T cell receptor (TCR) signaling and subsequently induce CD8+ T cell unresponsiveness [14].”
BackgroundHou, S., Lin, C., Fong, Y., & Tang, C. (2023) · Aging · doi:10.18632/aging.205230 · Cited by 19
“In addition, M1 macrophages express inducible nitric oxide synthase (iNOS) and play a role in initiating immune responses, including the activation of T cells and natural killer (NK) cells [12].”
BackgroundThe role of ANXA1 in the tumor microenvironment
Li, L., Wang, B., Zhao, S., Xiong, Q., & Cheng, A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111854 · Cited by 19
Yang, C., Zhang, D., Song, Z., Hou, Y., Bao, Y., Sun, L., Yu, C., & Li, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145095 · Cited by 20
“M2a macrophages can promote the recruitment of eosinophils and basophils by secreting CCL24 and CCL17 [16], and can promote tumor cell migration [37].”
BackgroundInfluentialZúñiga‐Castillo, M., Pereira, N. V., & Sotto, M. N. (2018) · Histopathology · doi:10.1111/his.13478 · Cited by 18
“Also, M2-Ms display the capability to expand the expression of the inhibitory co-factor of antigen presentation (programmed death ligand 1) in lymphocytes and impair the migration and increase the apoptosis of dendritic cells, finally inducing antigen tolerance.(14,15,17) The M2-Ms also facilitate tumoral growth, inva…”
BackgroundChanana, P., Uosef, A., Vaughn, N. R., Villagrán, M., Ghobrial, R. M., Kloc, M., & Wosik, J. (2022) · Cells · doi:10.3390/cells11050757 · Cited by 18
“The ionic ligands provide very strong binding between the Gd3+ and negatively charged carboxyl groups, while the non-ionic ligands have weaker binding between the Gd3+ and amide or alcohol functional groups [13,17].”
BackgroundMacrophage infiltration and genetic landscape of undifferentiated uterine sarcomas
Przybył, J., Kowalewska, M., Quattrone, A., Dewaele, B., Vanspauwen, V., Varma, S., Vennam, S., Newman, A. M., Świerniak, M., Bakuła‐Zalewska, E., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.94033 · Cited by 19
Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma
Handl, M., Hermanová, M., Hotárková, S., Jarkovský, J., Múdrý, P., Shatokhina, T., Vesela, M., Štěrba, J., & Zambo, I. S. (2017) · Biomedical Papers · doi:10.5507/bp.2017.049 · Cited by 18
Zhang, Y., Sha, W., Zhang, X., Cheng, M., Wu, Q., Wang, W., & Yuan, Z. (2019) · Biomaterials Science · doi:10.1039/c9bm01170f · Cited by 18
Yan, L., Gao, Y., Pierce, R., Dai, L., Kim, J. S., & Zhang, M. (2014) · Materials Research Express · doi:10.1088/2053-1591/1/2/025007 · Cited by 17
“Recent studies have suggested that therapy directly towards tumor microenvironment could circumvent the challenge of targeting highly heterogeneous breast cancer cells and impact the survival of patients regardless of tumor types and stages [2, 3].”
BackgroundChaudhari, N., Prakash, N., Pradeep, G., Mahajan, A. M., Lunawat, S., & Salunkhe, V. (2020) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_109_20 · Cited by 17
“There has been substantial clinical and experimental evidence that TAMs orchestrate all the stages of tumor progression.[5,11,23,24] M2 TAMs produce many immunomodulatory molecules including checkpoint inhibitors, and factors promoting angiogenesis[25] and tissue reconstruction, thus exerting trophic effects that exer…”
BackgroundThe portrayal of macrophages as tools and targets: A paradigm shift in cancer management
Jain, N., Srinivasarao, D. A., Famta, P., Shah, S., Vambhurkar, G. B., Shahrukh, S., Singh, S. B., & Srivastava, S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121399 · Cited by 17
The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential
Bannister, M. E., Chatterjee, D. A., Shetty, S., & Patten, D. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313167 · Cited by 17
Zhang, J., Liu, J., Zhang, H., Liu, B., Li, L., Li, Y., Pei, J., Lin, Q., Chen, Q., & Lin, J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101559 · Cited by 17
“Therefore, we also induced bone marrow-derived macrophages (BMDM) and used CD80 as an M1 macrophage marker to assess the phenotype of macrophages [29].”
The role of macrophages in liver metastasis: mechanisms and therapeutic prospects
Yuan, Q., Jia, L., Yang, J., & Li, W. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1542197 · Cited by 21
“They play an irreplaceable role in the maintenance of collective homeostasis (3 – 5).”
Rhein enhances the cytotoxicity of effector lymphocytes in colon cancer under hypoxic conditions
Yuan, X., Tian, W., Yang, H., Hu, L., Yang, J., Xie, J., Hu, J., & Wang, F. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6855 · Cited by 18
“…when tumor cells are exposed to hypoxic conditions, immuno-suppressive molecules including programmed cell death ligand-1 (PD-L1), vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), galectin-1, interleukin (IL)-10 and transforming growth factor-1 (TGF-β 1) are upregulated (6-10).”
de Brito, N. M., da-Costa, H. C., Simões, R. L., & Barja‐Fidalgo, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00540 · Cited by 18
“Conversely, M2 or alternatively activated macrophages produce higher amounts of antiinflammatory cytokines and participate in type 2 (Th2) reactions, inducing remodeling and tissue repair (3, 4).”
BackgroundWang, Y., Sun, L., Song, Z., Wang, D., Bao, Y., & Li, Y. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2016.12.021 · Cited by 17
“(C) Cells pretreated or M2b polarization, which is characterized by high IL-1 , TNF- , IL-6, IL-10, iNOS, and low IL-12 (Hao et al., 2012; Xiao et al., 2014).”
BackgroundInfluentialHypoxia and the Tumor Secretome
Liu, Y., Ciotti, G. E., & Eisinger‐Mathason, T. S. K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12734-3_4 · Cited by 18
Wedekind, H., Walz, K., Buchbender, M., Rieckmann, T., Strasser, E. F., Grottker, F., Fietkau, R., Frey, B., Gaipl, U. S., & Rückert, M. (2021) · Strahlentherapie und Onkologie · doi:10.1007/s00066-021-01856-4 · Cited by 19
Hatano, Y., Nakahama, K., Isobe, M., & Morita, I. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.113 · Cited by 17
Goswami, K. K., Barik, S., Banerjee, S., Bhowmick, A. K., Biswas, J., Bose, A., & Baral, R. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.09.003 · Cited by 18
Gong, T., Song, X., Yang, L., Chen, T., Zhao, T., Zheng, T., Sun, X., Gong, T., & Zhang, Z. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.048 · Cited by 17
Self-citationHong, J., Choi, E., Kim, D., Seo, M.-K., Kang, H., Park, B., & Kim, S. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00501-4 · Cited by 16
“Both pro-in fl ammatory M1-39 and anti-in fl ammatory M2-polar-ized macrophages 40 were elevated in the ED-derived subtypes; however, the ratio of M2 to M1 in the ID-derived subtypes was higher (Fig.”
BackgroundGao, K., Li, X., Luo, S., & Zhao, L. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5639 · Cited by 16
“By contrast, M2 macrophages can drive the TH2 response by secreting TGF‑ β 1 and IL‑10 (54,55).”
BackgroundDalpati, N., Rai, S. K., Dash, S. P., Kumar, P., Singh, D. K., & Sarangi, P. P. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400180 · Cited by 16
KLF4: a multifunctional nexus connecting tumor progression and immune regulation
Ju, Y., Xiao, W., Mathis, B. J., & Shi, Y. Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1514780 · Cited by 16
“Monocytes and macrophages are central for both innate and adaptive immunity and are closely associated with the pathogenesis of acute and chronic in fl ammatory diseases, as well as cancer (29).”
Tumor hypoxia: Classification, detection, and its critical role in cancer progression
Zhao, Y., Zhong, B., Cao, J., Wang, Q., Liang, J., Lu, K., & Lu, S. (2025) · Biomolecules and Biomedicine · doi:10.17305/bb.2025.12318 · Cited by 17
“M2 macrophages suppress anti-tumor responses by inhibiting T cell proliferation and effector functions [125].”
Pratiwi, R., Antara, N. Y., Fadliansyah, L. G., Ardiansyah, S. A., Nurhidayat, L., Sholikhah, E. N., Sunarti, S., Widyarini, S., Fadhlurrahman, A. G., Fatmasari, H., et al. (2019) · F1000Research · doi:10.12688/f1000research.20727.2 · Cited by 21
Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
Hanaki, R., Toyoda, H., Iwamoto, S., Morimoto, M., Nakato, D., Ito, T., Niwa, K., Amano, K., Hashizume, R., Tawara, I., et al. (2021) · Immunity Inflammation and Disease · doi:10.1002/iid3.503 · Cited by 16
“M2 macrophages suppress T cell responses by producing Arg‐1 enzyme that depletes L‐arginine, which is the substrate of iNOS.(33) In our study, M2 macrophages expressed higher Arg‐1 than M1 macrophages.”
BackgroundTan, L., Cheng, D., Wen, J., Huang, K., & Zhang, Q. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021384 · Cited by 17
Macrophages play a role in inflammatory transformation of colorectal cancer
Lu, L., Liu, Y.-J., Cheng, P., Hu, D., Xu, H.-C., & Ji, G. (2021) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v13.i12.2013 · Cited by 16
Zhang, L., Zheng, D., Yan, Y.-M., Yu, Y. Q., Chen, R., Li, Z., Greer, P. A., Peng, T., & Wang, Q. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02833-7 · Cited by 16
“Initially, 5 × 105 cells were incubated with the following monoclonal antibodies: F4/80 (eBioscience, 11–4801-81), CD206 (BioLegend, 141,705)and MHC II (eBioscience,17–5321-81).”
BackgroundInfluentialВасильевна, Б. А., & Belousov, P. V. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916110043 · Cited by 17
Zhai, X., Yuan, S., Yang, X. H., Zou, P., Shao, Y., El‐Aty, A. M. A., Hacımüftüoğlu, A., & Wang, J. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.004 · Cited by 16
Overcoming Immune Therapy Resistance in Cancer Through Innate Immune Reprogramming
Mandracci, G., Soliman, N., & Khawanky, N. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199554 · Cited by 15
Mahale, A. B., Routholla, G., Lavanya, S., Sharma, P., Ghosh, B., & Kulkarni, O. P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111921 · Cited by 15
Cabrales, P., Scicinski, J. J., Reid, T. R., Kuypers, F. A., Larkin, S. K., Fens, M. H. A. M., Oronsky, A. L., & Oronsky, B. T. (2016) · Medical Oncology · doi:10.1007/s12032-016-0775-3 · Cited by 15
Kang, J. Y., Gil, M., & Kim, K. E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051430 · Cited by 16
“Therefore, this study suggests that NRP1 expression induces the production of the inhibitory cytokines IL-10, IL-35, and TGFβ1 of the Treg cells and M2 macrophages, and the expressed cytokines serve as major signals in the immune suppression mechanism of STAD.”
BackgroundInfluential
Metadata
- Authors
- Hao, N.-B., Lü, M.-H., Fan, Y.-H., Cao, Y.-L., Zhang, Z.-R., & Yang, S.-M.
- Affiliations
- Army Medical University (CN)
- Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
- Biomedical Analysis Center, Third Military Medical University, Chongqing 40038, China
- Corresponding author
- Zhang, Zhi-Ren
- Venue
- Clinical and Developmental Immunology
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-11
- ISSN
- 1740-2522 (ISSN-L)
- 1740-2530
- PMC
- PMC3385963
- OpenAlex
- W2106027870
- Cited by
- 1,003
- References
- 121
- Citations by year
- 2026: 28 · 2025: 52 · 2024: 79 · 2023: 75 · 2022: 81 · 2021: 109 · 2020: 86 · 2019: 60 · 2018: 65 · 2017: 70 · 2016: 73 · 2015: 85 · 2014: 69 · 2013: 68 · 2012: 2
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Clinical and Developmental Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (31170851, 2010CB529406, 2009BA5045)
- National Basic Research Program of China (31170851, 2010CB529406, 2009BA5045)
- Chongqing Science Fund for Distinguished Young Scholars (31170851, 2010CB529406, 2009BA5045)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- tumor-associated macrophages, tumor microenvironment, macrophage polarization, M1 macrophages, M2 macrophages, immunosuppression, tumor angiogenesis, metastasis, cancer stem cells, drug resistance, macrophage-targeted therapy
- MeSH terms
- Animals, Humans, Macrophages, Neoplasms, Disease Progression, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.